R&D Advanced manufacturing to pave way for pharma industry The time for transition to sustainable strategies is now.
R&D JP Morgan 2023 - Stefan Weber and Ravi Anand pharmaphorum sits down with Stefan Weber and Ravi Anand of neurology-focused biotech Newron.
Webinars Sponsored Medical Informatics and Rare Disease: a bridge between two w... With more than 6,000 different diseases comprising the rare disease (RD) landscape, connecting patients and practitioners with the expertise needed to achieve th
R&D Rare Disease R&D: one step forward, but a long road ahead With over 40% of all medicines in the pipeline aimed at rare diseases, the future looks positive for increasing the number of treatments available.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
